EQS-Adhoc
LifeWatch AG: Withdrawal from INR market
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Miscellaneous
LifeWatch AG: Withdrawal from INR market
09-Jan-2017 / 17:30 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
---------------------------------------------------------------------------
LifeWatch AG: Withdrawal from INR market
09-Jan-2017 / 17:30 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
---------------------------------------------------------------------------
LifeWatch will withdraw from the INR market
Zug/Switzerland, January 9, 2017 - LifeWatch AG (SIX Swiss Exchange: LIFE),
a leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, announces its decision to
cease offering remote patient monitoring services in the area of INR
coagulation measurement.
LifeWatch Services, Inc., the US subsidiary of LifeWatch AG, entered into a
Stock Purchase Agreement (SPA) in November 2015 for the purchase of
Flexlife Health, Inc., a company offering patients the ability to use web-
based technology to transfer INR data and receive feedback from their
physician. LifeWatch today announces its decision to withdraw from the INR
market for commercial business reasons effective February 20, 2017.
The sellers of Flexlife initiated an arbitration action against LifeWatch
on January 5, 2017, seeking USD 5.5 million in liquidated damages for an
alleged default on the terms of the SPA. LifeWatch steadfastly denies
having defaulted on the SPA and intends to vigorously defend its decision
to withdraw from the INR market. LifeWatch is also exploring all options in
regard to its response to the arbitration action, including bringing its
own counterclaims against the sellers.
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Dynamics Group, Doris Rudischhauser
Phone +41 43 268 27 40 / Mobile +41 79 410 81 88
E-Mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote
diagnostic patient monitoring services. LifeWatch's services provide
physicians with critical information to determine appropriate treatment and
thereby improve patient outcomes. LifeWatch AG has operative subsidiaries
in the United States, in Switzerland and in Israel, and is the parent
company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd.
LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac
monitoring services. LifeWatch Technologies Ltd., based in Israel, is a
manufacturer of wireless digital health products. For additional
Zug/Switzerland, January 9, 2017 - LifeWatch AG (SIX Swiss Exchange: LIFE),
a leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, announces its decision to
cease offering remote patient monitoring services in the area of INR
coagulation measurement.
LifeWatch Services, Inc., the US subsidiary of LifeWatch AG, entered into a
Stock Purchase Agreement (SPA) in November 2015 for the purchase of
Flexlife Health, Inc., a company offering patients the ability to use web-
based technology to transfer INR data and receive feedback from their
physician. LifeWatch today announces its decision to withdraw from the INR
market for commercial business reasons effective February 20, 2017.
The sellers of Flexlife initiated an arbitration action against LifeWatch
on January 5, 2017, seeking USD 5.5 million in liquidated damages for an
alleged default on the terms of the SPA. LifeWatch steadfastly denies
having defaulted on the SPA and intends to vigorously defend its decision
to withdraw from the INR market. LifeWatch is also exploring all options in
regard to its response to the arbitration action, including bringing its
own counterclaims against the sellers.
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Dynamics Group, Doris Rudischhauser
Phone +41 43 268 27 40 / Mobile +41 79 410 81 88
E-Mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote
diagnostic patient monitoring services. LifeWatch's services provide
physicians with critical information to determine appropriate treatment and
thereby improve patient outcomes. LifeWatch AG has operative subsidiaries
in the United States, in Switzerland and in Israel, and is the parent
company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd.
LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac
monitoring services. LifeWatch Technologies Ltd., based in Israel, is a
manufacturer of wireless digital health products. For additional
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte